Sai Life Sciences Limited (NSE:SAILIFE)

India flag India · Delayed Price · Currency is INR
998.25
+33.75 (3.50%)
At close: Feb 27, 2026
40.52%
Market Cap 211.40B
Revenue (ttm) 21.70B
Net Income (ttm) 3.33B
Shares Out 211.77M
EPS (ttm) 15.54
PE Ratio 64.25
Forward PE 52.50
Dividend n/a
Ex-Dividend Date n/a
Volume 2,428,681
Average Volume 855,623
Open 962.05
Previous Close 964.50
Day's Range 956.00 - 1,004.70
52-Week Range 636.10 - 1,004.70
Beta n/a
RSI 64.82
Earnings Date Feb 5, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India. [Read more]

Sector Healthcare
Founded 1999
Employees 3,401
Stock Exchange National Stock Exchange of India
Ticker Symbol SAILIFE
Full Company Profile

Financial Performance

In fiscal year 2025, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.

Financial Statements

News

There is no news available yet.